Poor
Not Aligned
Patient Risk:
Moderate
Summary
Most AI statements discuss OTC/online-reported side effects and behavioral observations rather than claims supported or described in the provided FDA label excerpts; only the mechanism description is explicitly supported, and many statements are not addressable from the supplied label sections.
Category Scores
Accurate Statements
Voquezna (vonoprazan) is a potassium-competitive acid blocker.
Label 12.1: vonoprazan inhibits H+,K+-ATPase in a potassium-competitive manner and suppresses gastric acid secretion.
Voquezna is not a proton-pump inhibitor (PPI).
Label 12.1: vonoprazan is characterized as a type of gastric proton-pump inhibitor (i.e., the label describes it as a PPI-type).
Unsupported Statements
Voquezna side effects overlap with PPI side effects because both reduce stomach acid.
The provided label excerpts do not state that Voquezna side effects overlap with PPIs due to shared acid reduction.
Reddit users commonly report GI effects with Voquezna, including nausea, diarrhea, constipation, stomach discomfort, or indigestion-type symptoms.
The provided label excerpts do not include or support claims about frequency or content of adverse effects based on Reddit reports.
Reddit users commonly report headache or general fatigue with Voquezna.
The provided label excerpts do not support claims about headache/fatigue frequency from Reddit.
Reddit users report changes in appetite with Voquezna.
The provided label excerpts do not support appetite-change reports from Reddit.
Reddit users sometimes report symptoms that resemble infections or “weird gut” feelings after starting Voquezna.
The provided label excerpts do not support or quantify such Reddit-reported symptom descriptions.
Users who switch from a PPI to Voquezna often ask whether symptoms like reflux, bloating, or diarrhea improve or worsen.
The provided label excerpts do not address patient questions or switching experiences between PPIs and Voquezna.
Persistent diarrhea or stomach upset after starting Voquezna is a common side-effect concern reported in Reddit discussions.
The provided label excerpts discuss diarrhea risk in warnings/precautions (e.g., CDAD) but do not support 'common' or Reddit-based framing.
Symptoms that could signal infection (for example, ongoing GI symptoms that do not settle) are a common side-effect concern reported in Reddit discussions.
Not supported by the provided label excerpts; also reframes label warnings without support.
Headaches that affect daily functioning are a common side-effect concern reported in Reddit discussions.
Not supported by the provided label excerpts.
Symptoms that make users think the medicine “isn’t agreeing with them” are a common side-effect concern reported in Reddit discussions.
Not supported by the provided label excerpts.
Reddit users may attempt to connect the timing of symptoms to the first dose or to dose changes of Voquezna.
Not addressed in the provided label excerpts.
Contacting a clinician is advised for severe or escalating symptoms in people reporting side effects on Reddit.
The label excerpts provided do not give advice framed as 'for Reddit users'; while warnings exist, the specific recommendation phrasing and 'severe or escalating symptoms' tied to Reddit is not supported.
Trouble breathing, facial/lip swelling, or widespread rash are treated as possible allergy signs that warrant urgent help for someone on Voquezna.
The provided label excerpt includes severe cutaneous adverse reactions and hypersensitivity discontinuation, but does not explicitly map these particular symptoms to 'urgent help' wording.
Severe or worsening abdominal pain, blood in stool, or black/tarry stools are treated as urgent-help signs for someone on Voquezna.
The provided label excerpts do not mention these specific signs as urgent-help thresholds.
Persistent vomiting, dehydration, or symptoms that rapidly escalate are treated as urgent-help signs for someone on Voquezna.
Not supported by the provided label excerpts.
Side effects that are mild but keep coming back lead some users to ask whether it is worth continuing long enough for the body to adjust or whether switching therapy is needed.
Not addressed in the provided label excerpts.
Reddit anecdotes do not show how common a side effect is or whether symptoms were caused by Voquezna versus the condition being treated (GERD, H. pylori, gastritis).
This is a general epistemic statement about anecdotes; it is not supported or contradicted by the provided label excerpts.
Reddit anecdotes do not show whether other medications (like antibiotics used for H. pylori) contributed to symptoms.
Not addressed by the provided label excerpts.
Official prescribing information and drug references are sources for drug-specific adverse reactions and labeling for Voquezna.
Not directly stated in the provided label excerpts; however it is not contradicted either (can’t be confirmed from provided excerpts).
Contradictions
Low
AI Statement
Voquezna is not a proton-pump inhibitor (PPI).
Label Reference
Label 12.1: "Vonoprazan has been characterized as a type of gastric proton-pump inhibitor..."
Important Omissions
The AI did not cite or reflect any label-based adverse reactions list or specific warnings/precautions (e.g., acute tubulointerstitial nephritis, CDAD, severe cutaneous adverse reactions, vitamin B12 deficiency, hypomagnesemia) when discussing side effects.
Importance:
Moderate
Safety Assessment
Potential Patient Risk:
Moderate
The response contains multiple unsupported claims about side-effect frequency and urgency based on Reddit and includes a contradiction about PPI classification, which could mislead users about expected label-based risks.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
No |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
High |
Recommendation
Not Aligned
Primary Issue
Contradicts label classification (PPI), and uses Reddit-based frequency/urgency claims not supported by the provided FDA label excerpts.
Suggested Improvement
Replace Reddit-based frequency/urgency statements with label-supported warnings/precautions and adverse reaction references; ensure the mechanism/classification statement matches Label 12.1.